Answers are grounded in this paper and cite their sources.
An oral hypoglycemic drug (Diabinese-chlorpropamide) was given inadvertently to a nondiabetic with renal insufficiency instead of the prescribed phosphate binder (Dialume-aluminum hydroxide). It was determined from this situation that hemodialysis is of no benefit in removing the drug from serum; the hypoglycemic effect of chlorpropamide is profound in nondiabetics, and the duration of therapy with dextrose infusions can be quite prolonged. We provide recommendations regarding therapy, bedside glucose monitoring, and prevention.
No takes yet. Share an insight, caveat, or question.
Whelan et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: